Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Michael S Brown. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Michael S Brown har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:REGN / Regeneron Pharmaceuticals, Inc. | Director | 1 548 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Michael S Brown. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Michael S Brown som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 166 | 1 548 | 12,01 | ||||
2024-06-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 535 | 1 382 | −52,62 | 1 040,00 | −1 596 400 | 1 437 280 |
2024-06-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 1 535 | 2 917 | 111,07 | 625,60 | 960 296 | 1 824 875 |
2024-05-29 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 172 | 1 382 | −45,89 | 974,86 | −1 142 536 | 1 347 257 |
2024-05-29 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 1 172 | 2 554 | 84,80 | 625,60 | 733 203 | 1 597 782 |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 135 | 1 382 | 10,83 | ||||
2023-12-29 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 049 | 1 247 | −62,17 | 898,00 | −1 840 002 | 1 119 806 |
2023-12-29 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 049 | 3 296 | 164,31 | 482,68 | 989 011 | 1 590 913 |
2023-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 070 | 1 247 | −71,11 | 798,42 | −2 451 149 | 995 630 |
2023-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 3 070 | 4 317 | 246,19 | 520,01 | 1 596 431 | 2 244 883 |
2023-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −500 | 6 162 | −7,51 | 797,00 | −398 500 | 4 911 114 |
2023-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 071 | 1 247 | −71,12 | 798,00 | −2 450 658 | 995 106 |
2023-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 3 071 | 4 318 | 246,27 | 520,01 | 1 596 951 | 2 245 403 |
2023-01-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 | 1 247 | −0,08 | 747,00 | −747 | 931 509 |
2023-01-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 1 | 1 248 | 0,08 | 520,01 | 520 | 648 972 |
2023-01-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 070 | 1 247 | −71,11 | 747,14 | −2 293 720 | 931 684 |
2023-01-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 3 070 | 4 317 | 246,19 | 520,01 | 1 596 431 | 2 244 883 |
2023-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 165 | 1 247 | 15,25 | ||||
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −500 | 6 662 | −6,98 | 748,49 | −374 245 | 4 986 440 |
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −200 | 1 082 | −15,60 | 768,11 | −153 622 | 831 095 |
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −201 | 1 282 | −13,55 | 767,25 | −154 217 | 983 614 |
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −201 | 1 483 | −11,94 | 766,74 | −154 115 | 1 137 075 |
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −100 | 1 684 | −5,61 | 765,19 | −76 519 | 1 288 580 |
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −200 | 1 784 | −10,08 | 764,23 | −152 846 | 1 363 386 |
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −200 | 1 984 | −9,16 | 763,19 | −152 638 | 1 514 169 |
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −100 | 2 184 | −4,38 | 761,53 | −76 153 | 1 663 182 |
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −200 | 2 284 | −8,05 | 760,70 | −152 140 | 1 737 439 |
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −200 | 2 484 | −7,45 | 754,70 | −150 940 | 1 874 675 |
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −300 | 2 684 | −10,05 | 753,66 | −226 098 | 2 022 823 |
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −203 | 2 984 | −6,37 | 752,14 | −152 684 | 2 244 386 |
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −126 | 3 187 | −3,80 | 751,23 | −94 655 | 2 394 170 |
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 1 564 | 3 313 | 89,42 | 482,68 | 754 912 | 1 599 119 |
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 764 | 1 749 | −50,21 | 748,48 | −1 320 319 | 1 309 092 |
2022-11-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 431 | 3 513 | 224,68 | 374,12 | 909 486 | 1 314 284 |
2022-03-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −408 | 2 431 | −14,37 | |||
2022-03-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −408 | 1 082 | −27,38 | 699,00 | −285 192 | 756 318 |
2022-03-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 408 | 1 490 | 37,71 | 374,12 | 152 641 | 557 439 |
2022-03-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 522 | 2 839 | −34,90 | |||
2022-03-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 522 | 1 082 | −58,45 | 699,00 | −1 063 878 | 756 318 |
2022-03-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 1 522 | 2 604 | 140,67 | 374,12 | 569 411 | 974 208 |
2022-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −500 | 7 162 | −6,53 | 608,68 | −304 340 | 4 359 366 | |
2022-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 2 707 | 2 707 | |||||
2022-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 191 | 1 082 | 21,44 | ||||
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 612 | 0 | −100,00 | |||
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 613 | 3 612 | −50,01 | |||
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 479 | 0 | −100,00 | |||
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −62 | 891 | −6,51 | 652,26 | −40 440 | 581 164 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 712 | 953 | −79,57 | 651,10 | −2 416 883 | 620 498 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 800 | 4 665 | −27,84 | 650,40 | −1 170 720 | 3 034 116 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −838 | 6 465 | −11,47 | 649,46 | −544 247 | 4 198 759 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −962 | 7 303 | −11,64 | 648,48 | −623 838 | 4 735 849 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −151 | 8 265 | −1,79 | 647,58 | −97 785 | 5 352 249 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −100 | 8 416 | −1,17 | 646,28 | −64 628 | 5 439 092 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −100 | 8 516 | −1,16 | 645,66 | −64 566 | 5 498 441 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −100 | 8 616 | −1,15 | 644,89 | −64 489 | 5 556 372 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −100 | 8 716 | −1,13 | 643,49 | −64 349 | 5 608 659 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −400 | 8 816 | −4,34 | 642,62 | −257 048 | 5 665 338 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −100 | 9 216 | −1,07 | 641,12 | −64 112 | 5 908 562 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −100 | 9 316 | −1,06 | 640,77 | −64 077 | 5 969 413 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −203 | 9 416 | −2,11 | 639,20 | −129 758 | 6 018 707 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −676 | 9 619 | −6,57 | 638,64 | −431 721 | 6 143 078 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −200 | 10 295 | −1,91 | 637,29 | −127 458 | 6 560 901 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −100 | 10 495 | −0,94 | 636,74 | −63 674 | 6 682 586 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 3 612 | 10 595 | 51,73 | 413,33 | 1 492 948 | 4 379 231 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 3 613 | 6 983 | 107,21 | 413,33 | 1 493 361 | 2 886 283 |
2021-09-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 479 | 3 370 | 278,23 | 380,95 | 944 375 | 1 283 802 |
2021-08-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −1 687 | 7 662 | −18,04 | 612,38 | −1 033 085 | 4 692 056 | |
2021-06-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 084 | 0 | −100,00 | |||
2021-06-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 084 | 891 | −70,05 | 549,00 | −1 144 116 | 489 159 |
2021-06-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 084 | 2 975 | 233,89 | 371,40 | 773 998 | 1 104 915 |
2021-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 700 | 2 084 | −44,93 | |||
2021-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 700 | 891 | −65,61 | 525,00 | −892 500 | 467 775 |
2021-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 1 700 | 2 591 | 190,80 | 371,40 | 631 380 | 962 297 |
2021-01-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 480 | 2 479 | −50,01 | |||
2021-01-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 480 | 891 | −73,57 | 554,32 | −1 374 714 | 493 899 |
2021-01-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 480 | 3 371 | 278,34 | 380,95 | 944 756 | 1 284 182 |
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 3 613 | 3 613 | |||||
2021-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 248 | 891 | 38,57 | ||||
2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 480 | 4 959 | −33,34 | |||
2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 610 | 0 | −100,00 | |||
2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 000 | 9 349 | −9,66 | 552,36 | −552 360 | 5 164 014 |
2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −5 090 | 643 | −88,78 | 552,36 | −2 811 512 | 355 167 |
2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 610 | 5 733 | 83,57 | 376,69 | 983 161 | 2 159 564 |
2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 480 | 3 123 | 385,69 | 380,95 | 944 756 | 1 189 707 |
2020-09-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −1 000 | 10 349 | −8,81 | ||||
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 613 | 7 225 | −33,34 | |||
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −400 | 643 | −38,35 | 612,29 | −244 916 | 393 702 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −200 | 1 043 | −16,09 | 607,35 | −121 470 | 633 466 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −6 | 1 243 | −0,48 | 624,19 | −3 745 | 775 868 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −100 | 1 249 | −7,41 | 623,07 | −62 307 | 778 214 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −200 | 1 349 | −12,91 | 616,49 | −123 298 | 831 645 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −100 | 1 549 | −6,06 | 615,23 | −61 523 | 952 991 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −200 | 1 649 | −10,82 | 609,51 | −121 902 | 1 005 082 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −319 | 1 849 | −14,71 | 608,59 | −194 140 | 1 125 283 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −401 | 2 168 | −15,61 | 605,78 | −242 918 | 1 313 331 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −960 | 2 569 | −27,20 | 604,82 | −580 627 | 1 553 783 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −627 | 3 529 | −15,09 | 603,39 | −378 326 | 2 129 363 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −100 | 4 156 | −2,35 | 601,70 | −60 170 | 2 500 665 |
2020-07-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 3 613 | 4 256 | 561,90 | 413,33 | 1 493 361 | 1 759 132 |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −1 809 | 643 | −73,78 | 562,00 | −1 016 658 | 361 366 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 220 | 2 610 | −66,67 | ||||
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −250 | 0 | −100,00 | ||||
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −123 | 2 452 | −4,78 | 555,77 | −68 360 | 1 362 748 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 250 | 2 575 | 10,75 | 273,67 | 68 418 | 704 700 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −3 538 | 2 325 | −60,34 | 555,77 | −1 966 314 | 1 292 165 | |
2020-05-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 5 220 | 5 863 | 811,82 | 376,69 | 1 966 322 | 2 208 533 | |
2020-02-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 000 | 250 | −88,89 | |||
2020-02-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −44 | 643 | −6,40 | 419,03 | −18 437 | 269 436 |
2020-02-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 956 | 687 | −74,01 | 419,00 | −819 564 | 287 853 |
2020-02-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 2 643 | 311,04 | 273,67 | 547 340 | 723 310 |
2020-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 4 361 | 4 361 | |||||
2020-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 320 | 643 | 99,07 | ||||
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −4 000 | 2 250 | −64,00 | |||
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 585 | 323 | −83,07 | 374,86 | −594 153 | 121 080 |
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 400 | 1 908 | −42,32 | 373,91 | −523 474 | 713 420 |
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 015 | 3 308 | −23,48 | 372,75 | −378 341 | 1 233 057 |
2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 4 000 | 4 323 | 1 238,39 | 273,67 | 1 094 680 | 1 183 075 |
2019-11-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −4 500 | 6 250 | −41,86 | |||
2019-11-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | −1 000 | 11 349 | −8,10 | ||||
2019-11-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −4 500 | 323 | −93,30 | 349,00 | −1 570 500 | 112 727 |
2019-11-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 4 500 | 4 823 | 1 393,19 | 273,67 | 1 231 515 | 1 319 910 |
2019-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 784 | 3 784 | |||||
2019-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
A - Award | 323 | 323 | |||||
2018-09-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 000 | 10 750 | −15,69 | |||
2018-09-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −260 | 0 | −100,00 | 395,42 | −102 809 | |
2018-09-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −40 | 260 | −13,33 | 394,43 | −15 777 | 102 552 |
2018-09-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 300 | −50,00 | 393,49 | −118 047 | 118 047 |
2018-09-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −410 | 600 | −40,59 | 392,37 | −160 872 | 235 422 |
2018-09-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −601 | 1 010 | −37,31 | 391,38 | −235 219 | 395 294 |
2018-09-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −389 | 1 611 | −19,45 | 390,23 | −151 799 | 628 661 |
2018-09-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 273,67 | 547 340 | 547 340 | |
2018-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2018-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 500 | 0 | −100,00 | 380,49 | −570 735 | ||
2018-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 500 | 1 500 | 177,82 | 266 730 | 266 730 | ||
2018-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −5 000 | 12 349 | −28,82 | ||||
2018-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | 5 000 | 5 000 | |||||
2018-01-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 7 439 | 7 439 | |||||
2017-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 500 | 1 500 | −50,00 | |||
2017-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 0 | −100,00 | 475,00 | −712 500 | |
2017-10-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 500 | 1 500 | 177,82 | 266 730 | 266 730 | |
2017-06-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 000 | 3 000 | −50,00 | |||
2017-06-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 0 | −100,00 | 500,00 | −1 500 000 | |
2017-06-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 177,82 | 533 460 | 533 460 | |
2017-06-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 000 | 6 000 | −25,00 | |||
2017-06-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −606 | 0 | −100,00 | 475,72 | −288 286 | |
2017-06-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −900 | 606 | −59,76 | 474,37 | −426 933 | 287 468 |
2017-06-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 1 506 | −11,72 | 473,37 | −94 674 | 712 895 |
2017-06-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −94 | 1 706 | −5,22 | 469,02 | −44 088 | 800 148 |
2017-06-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 1 800 | −5,26 | 477,05 | −47 705 | 858 690 |
2017-06-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 1 900 | −5,00 | 472,04 | −47 204 | 896 876 |
2017-06-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 177,82 | 355 640 | 355 640 | |
2017-05-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 000 | 8 000 | −27,27 | |||
2017-05-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 0 | −100,00 | 450,00 | −1 350 000 | |
2017-05-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 177,82 | 533 460 | 533 460 | |
2017-03-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −1 000 | 11 000 | −8,33 | |||
2017-03-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 0 | −100,00 | 400,00 | −400 000 | |
2017-03-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 1 000 | 177,82 | 177 820 | 177 820 | |
2017-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 7 830 | 7 830 | |||||
2016-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 9 212 | 9 212 | |||||
2016-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −1 000 | 17 349 | −5,45 | ||||
2015-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 000 | 12 000 | −20,00 | |||
2015-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 199 | 0 | −100,00 | 547,50 | −656 452 | |
2015-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 003 | 1 199 | −45,55 | 546,36 | −547 999 | 655 086 |
2015-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −598 | 2 202 | −21,36 | 545,41 | −326 155 | 1 200 993 |
2015-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 2 800 | −3,45 | 544,03 | −54 403 | 1 523 284 |
2015-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 2 900 | −3,33 | 543,55 | −54 355 | 1 576 295 |
2015-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 177,82 | 533 460 | 533 460 | |
2015-09-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 000 | 0 | −100,00 | |||
2015-09-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 0 | −100,00 | 551,55 | −1 654 650 | |
2015-09-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 57,11 | 171 330 | 171 330 | |
2015-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −5 000 | 3 000 | −62,50 | |||
2015-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 495,00 | −2 475 000 | |
2015-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 57,11 | 285 550 | 285 550 | |
2015-02-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 000 | 8 000 | −11,11 | ||||
2015-02-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 000 | 0 | −100,00 | 422,72 | −422 720 | ||
2015-02-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 000 | 1 000 | 57,11 | 57 110 | 57 110 | ||
2015-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 10 838 | 10 838 | |||||
2015-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −2 000 | 18 349 | −9,83 | ||||
2014-10-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −5 000 | 9 000 | −35,71 | |||
2014-10-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 0 | −100,00 | 399,00 | −1 995 000 | |
2014-10-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 5 000 | 57,11 | 285 550 | 285 550 | |
2014-08-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 000 | 0 | −100,00 | |||
2014-08-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 0 | −100,00 | 349,20 | −1 047 600 | |
2014-08-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 33,42 | 100 260 | 100 260 | |
2014-08-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −2 700 | 0 | −100,00 | ||||
2014-07-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Class A Stock |
C - Conversion | −5 687 | 0 | −100,00 | ||||
2014-07-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | 5 687 | 20 349 | 38,79 | ||||
2014-07-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −5 687 | 0 | −100,00 | ||||
2014-07-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
C - Conversion | 5 687 | 5 687 | |||||
2014-07-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | 14 662 | 14 662 | |||||
2014-07-31 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −14 662 | 0 | −100,00 | ||||
2014-03-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 000 | 3 000 | −40,00 | |||
2014-03-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 14 662 | −2,01 | 336,49 | −100 947 | 4 933 616 |
2014-03-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 14 962 | −0,66 | 335,69 | −33 569 | 5 022 594 |
2014-03-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 15 062 | −3,21 | 334,59 | −167 295 | 5 039 595 |
2014-03-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 100 | 15 562 | −6,60 | 333,42 | −366 762 | 5 188 682 |
2014-03-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 16 662 | 13,64 | 33,42 | 66 840 | 556 844 |
2014-03-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Class A Stock |
C - Conversion | −2 700 | 0 | −100,00 | ||||
2014-03-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
C - Conversion | 2 700 | 2 700 | |||||
2014-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 000 | 14 662 | −6,38 | 335,00 | −335 000 | 4 911 770 | |
2014-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 000 | 14 000 | −6,67 | ||||
2014-02-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 000 | 15 662 | 6,82 | 57,11 | 57 110 | 894 457 | |
2014-01-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12 750 | 12 750 | |||||
2013-09-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −5 000 | 5 000 | −50,00 | |||
2013-09-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 14 662 | −25,43 | 309,00 | −1 545 000 | 4 530 558 |
2013-09-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 19 662 | 34,10 | 33,42 | 167 100 | 657 104 |
2013-09-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −5 000 | 10 000 | −33,33 | |||
2013-09-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 14 662 | −0,68 | 296,00 | −29 600 | 4 339 952 |
2013-09-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 400 | 14 762 | −8,66 | 294,81 | −412 734 | 4 351 985 |
2013-09-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 200 | 16 162 | −6,91 | 294,09 | −352 908 | 4 753 083 |
2013-09-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 300 | 17 362 | −11,70 | 292,60 | −672 980 | 5 080 121 |
2013-09-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 19 662 | 34,10 | 33,42 | 167 100 | 657 104 |
2013-05-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −4 900 | 14 662 | −25,05 | 269,00 | −1 318 100 | 3 944 078 | |
2013-05-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −100 | 19 562 | −0,51 | 270,20 | −27 020 | 5 285 652 | |
2013-05-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2013-05-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 10 000 | −33,33 | ||||
2013-05-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 000 | 19 662 | −33,71 | 278,28 | −2 782 800 | 5 471 541 | |
2013-05-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 29 662 | 50,86 | 24,41 | 244 100 | 724 049 | |
2013-05-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 000 | 19 662 | 34,10 | 24,41 | 122 050 | 479 949 | |
2013-03-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 240 | 0 | −100,00 | |||
2013-03-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −6 760 | 3 240 | −67,60 | |||
2013-03-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 000 | 10 000 | −23,08 | |||
2013-03-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 000 | 13 000 | −13,33 | |||
2013-03-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 240 | 14 662 | −18,10 | 172,61 | −559 256 | 2 530 808 |
2013-03-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 240 | 17 902 | 22,10 | 18,61 | 60 296 | 333 156 |
2013-03-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 760 | 14 662 | −31,56 | 173,31 | −1 171 576 | 2 541 071 |
2013-03-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 760 | 21 422 | 46,11 | 18,61 | 125 804 | 398 663 |
2013-03-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 14 662 | −16,99 | 173,31 | −519 930 | 2 541 071 |
2013-03-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 17 662 | 20,46 | 18,61 | 55 830 | 328 690 |
2013-03-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 14 662 | −12,00 | 174,13 | −348 260 | 2 553 094 |
2013-03-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 16 662 | 13,64 | 18,61 | 37 220 | 310 080 |
2013-01-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 000 | 0 | −100,00 | ||||
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −7 000 | 14 662 | −32,31 | 147,03 | −1 029 210 | 2 155 754 | |
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 000 | 21 662 | 47,74 | 23,84 | 166 880 | 516 422 | |
2012-10-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 000 | 7 000 | −30,00 | ||||
2012-10-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 000 | 14 662 | −16,99 | 154,69 | −464 070 | 2 268 065 | |
2012-10-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 000 | 17 662 | 20,46 | 23,84 | 71 520 | 421 062 | |
2012-10-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 000 | 10 000 | −16,67 | ||||
2012-10-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 000 | 14 662 | −12,00 | 155,34 | −310 680 | 2 277 595 | |
2012-10-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 000 | 16 662 | 13,64 | 23,84 | 47 680 | 397 222 | |
2012-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 000 | 12 000 | −20,00 | ||||
2012-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 000 | 14 662 | −16,99 | 136,29 | −408 870 | 1 998 284 | |
2012-08-07 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 000 | 17 662 | 20,46 | 23,84 | 71 520 | 421 062 | |
2012-03-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 700 | 0 | −100,00 | |||
2012-03-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −7 300 | 2 700 | −73,00 | |||
2012-03-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −626 | 10 000 | −5,89 | |||
2012-03-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −4 374 | 10 626 | −29,16 | |||
2012-03-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −5 000 | 0 | −100,00 | |||
2012-03-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 700 | 14 662 | −15,55 | 104,32 | −281 664 | 1 529 540 |
2012-03-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 700 | 17 362 | 18,41 | 19,69 | 53 163 | 341 858 |
2012-03-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 300 | 14 662 | −33,24 | 103,39 | −754 747 | 1 515 904 |
2012-03-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 300 | 21 962 | 49,79 | 19,69 | 143 737 | 432 432 |
2012-03-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 14 662 | −25,43 | 103,06 | −515 300 | 1 511 066 |
2012-03-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 19 662 | 34,10 | 15,80 | 79 000 | 310 660 |
2012-03-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −626 | 14 662 | −4,09 | 103,01 | −64 484 | 1 510 333 |
2012-03-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 626 | 15 288 | 4,27 | 19,69 | 12 326 | 301 021 |
2012-03-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 374 | 14 662 | −22,98 | 102,65 | −448 991 | 1 505 054 |
2012-03-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 374 | 19 036 | 29,83 | 19,69 | 86 124 | 374 819 |
2012-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2007-01-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2004-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 |